Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Increasing off-label use of antipsychotic medications in the United States, 1995-2008.

Alexander GC, Gallagher SA, Mascola A, Moloney RM, Stafford RS.

Pharmacoepidemiol Drug Saf. 2011 Feb;20(2):177-84. doi: 10.1002/pds.2082. Epub 2011 Jan 6.

2.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
3.

Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.

Carton L, Cottencin O, Lapeyre-Mestre M, Geoffroy PA, Favre J, Simon N, Bordet R, Rolland B.

Curr Pharm Des. 2015;21(23):3280-97. Review.

PMID:
26088115
4.

[Positive and negative aspects of pharmaceutical services in Spain: about antidepressants and antipsychotics].

Girona-Brumós L, Ribera-Montañá R, Juárez-Giménez JC, Pilar Lalueza-Broto M.

Gac Sanit. 2006 Mar;20 Suppl 1:143-53. Review. Spanish.

5.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
6.

Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.

Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, Wang Z, Timmer M, Sultzer D, Shekelle PG.

JAMA. 2011 Sep 28;306(12):1359-69. doi: 10.1001/jama.2011.1360. Review. Erratum in: JAMA. 2012 Jan 11;307(2):147.

PMID:
21954480
7.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
8.

A review of pharmacoepidemiologic studies of antipsychotic use in children and adolescents.

Patten SB, Waheed W, Bresee L.

Can J Psychiatry. 2012 Dec;57(12):717-21. Review.

PMID:
23228229
9.

Use of antipsychotic medications in pediatric populations: what do the data say?

Penfold RB, Stewart C, Hunkeler EM, Madden JM, Cummings JR, Owen-Smith AA, Rossom RC, Lu CY, Lynch FL, Waitzfelder BE, Coleman KJ, Ahmedani BK, Beck AL, Zeber JE, Simon GE.

Curr Psychiatry Rep. 2013 Dec;15(12):426. doi: 10.1007/s11920-013-0426-8. Review. Erratum in: Curr Psychiatry Rep. 2014 Feb;16(2):432. Coleman, Karen A [corrected to Coleman, Karen J].

10.

Clozapine: a review of clinical practice guidelines and prescribing trends.

Warnez S, Alessi-Severini S.

BMC Psychiatry. 2014 Apr 7;14:102. doi: 10.1186/1471-244X-14-102. Review.

11.

[Treatment of borderline personality disorder with atypical antipsychotic drugs].

Mobascher A, Mobascher J, Schmahl C, Malevani J.

Nervenarzt. 2007 Sep;78(9):1003-13. Review. German.

PMID:
17294149
12.

Use of pharmaceuticals 'off-label' in the neonate.

Tobin JR.

Best Pract Res Clin Anaesthesiol. 2010 Sep;24(3):451-60. Review.

PMID:
21033019
13.

Off -Label Use of Atypical Antipsychotic Drugs: A Summary for Clinicians and Policymakers.

Eisenberg Center at Oregon Health & Science University.

Comparative Effectiveness Review Summary Guides for Clinicians [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2007-.
2007 Jul 12.

14.

Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment [Internet].

Abernethy AP, Coeytaux RR, Carson K, McCrory D, Barbour SY, Gradison M, Irvine RJ, Wheeler JL.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Jan 29.

Supplemental Content

Support Center